| 臺大學術典藏 |
2020-10-14T07:24:49Z |
Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation/variant/haplotype and Tumor Necrosis Factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis
|
Kuo C.-H.; Su Y.-N.; Su T.-C.; Liang P.-C.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2020-10-14T07:24:48Z |
Association of novel chymotrypsin C gene variations and haplotypes in patients with chronic pancreatitis in Chinese in Taiwan
|
Kuo C.-H.; Wong J.-M.; Su Y.-N.; Jan I.-S.; Liang P.-C.; Chang Y.-T.; SHU-CHEN WEI; Chang M.-C. |
| 臺大學術典藏 |
2020-10-14T07:24:47Z |
Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis
|
Chang Y.-T.; Chang M.-C.; Su T.-C.; Liang P.-C.; Su Y.-N.; Kuo C.-H.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2020-10-14T07:24:43Z |
Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
|
Liang P.-C.; Chang M.-C.; Jan I.-S.; Yang C.-Y.; Tien Y.-W.; SHU-CHEN WEI; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2020-10-14T07:24:42Z |
Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels
|
Wong J.-M.; Chang Y.-T.; SHU-CHEN WEI; Yang C.-Y.; Tien Y.-W.; Jan S.; Chang M.-C.; Liang P.-C. |
| 臺大學術典藏 |
2020-09-28T02:47:57Z |
Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis
|
Chang M.-C.;Chang Y.-T.;Ta-Chen Su;Yang W.-S.;Chen C.-L.;Tien Y.-W.;Liang P.-C.;Wei S.-C.;Wong J.-M.; Chang M.-C.; Chang Y.-T.; TA-CHEN SU; Yang W.-S.; Chen C.-L.; Tien Y.-W.; Liang P.-C.; Wei S.-C.; Wong J.-M. |
| 臺大學術典藏 |
2020-09-28T02:47:55Z |
Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation/variant/haplotype and Tumor Necrosis Factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis
|
Chang Y.-T.; Chang M.-C.; TA-CHEN SU; Liang P.-C.; Su Y.-N.; Kuo C.-H.; Wei S.-C.; Wong J.-M. |
| 臺大學術典藏 |
2020-09-28T02:47:49Z |
Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis
|
Chang Y.-T.;Chang M.-C.;Ta-Chen Su;Liang P.-C.;Su Y.-N.;Kuo C.-H.;Wei S.-C.;Wong J.-M.; Chang Y.-T.; Chang M.-C.; TA-CHEN SU; Liang P.-C.; Su Y.-N.; Kuo C.-H.; Wei S.-C.; Wong J.-M. |
| 臺大學術典藏 |
2020-09-22T09:06:01Z |
Disease-free survival assessment by artificial?neural networks for hepatocellular carcinoma patients after radiofrequency ablation
|
Wu C.-F.; Wu Y.-J.; Liang P.-C.; Wu C.-H.; STEVEN SHINN-FORNG PENG; Chiu H.-W. |
| 臺大學術典藏 |
2020-09-22T08:51:42Z |
Disease-free survival assessment by artificial?neural networks for hepatocellular carcinoma patients after radiofrequency ablation
|
Wu Y.-J.; Liang P.-C.; Wu C.-H.; Peng S.-F.; Chiu H.-W.; Wu C.-F. |
| 臺大學術典藏 |
2020-09-22T07:39:53Z |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Lin Y.-H.; Hwang R.-M.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Shih T.T.F. |
| 臺大學術典藏 |
2020-09-22T07:39:52Z |
Quantification of hepatic steatosis: A comparison of the accuracy among multiple magnetic resonance techniques
|
Wu C.-H.; Ho M.-C.; Jeng Y.-M.; CHAO-YU HSU; Liang P.-C.; Hu R.-H.; Lai H.-S.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-09-22T07:39:52Z |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-09-22T07:39:51Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Hsu C.; Liang P.-C.; Chen B.-B.; CHAO-YU HSU; Yu C.-W. |
| 臺大學術典藏 |
2020-09-22T07:39:50Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Chao-Yu Hsu;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-14T03:15:33Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Chen B.-B.; I-LUN SHIH; Wu C.-H.; Hsu C.; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C. |
| 臺大學術典藏 |
2020-08-12T02:42:40Z |
Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan
|
Jeng Y.-M.; Chang Y.-T.; Chang M.-C.;Wu C.-H.;Yang S.-H.;Liang P.-C.;Bang-Bin Chen;Jan I.-S.;Chang Y.-T.;Jeng Y.-M.; Chang M.-C.; Wu C.-H.; Yang S.-H.; Liang P.-C.; BANG-BIN CHEN; Jan I.-S. |
| 臺大學術典藏 |
2020-08-12T02:42:39Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Bang-Bin Chen;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; BANG-BIN CHEN; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-07T02:32:19Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Chen B.-B.; Shih I.-L.; CHIH-HORNG WU; Hsu C.; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C. |
| 臺大學術典藏 |
2020-08-07T02:32:19Z |
The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism
|
Huang K.-W.; CHIH-HORNG WU; Shih T.T.-F.; Lai H.-S.; Liang P.-C. |
| 臺大學術典藏 |
2020-08-07T02:32:16Z |
Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan
|
Chang M.-C.;Chih-Horng Wu;Yang S.-H.;Liang P.-C.;Chen B.-B.;Jan I.-S.;Chang Y.-T.;Jeng Y.-M.; Chang M.-C.; CHIH-HORNG WU; Yang S.-H.; Liang P.-C.; Chen B.-B.; Jan I.-S.; Chang Y.-T.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-08-07T02:32:15Z |
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
|
CHIH-HORNG WU; Huang K.-W.; Ho C.-M.; Hu R.-H.; Ho M.-C.; Wu Y.-M.; Lee P.-H.; Liang P.-C.; Liu K.-L.; Lee B.-C.; Lee B.-C.;Liu K.-L.;Chih-Horng Wu;Huang K.-W.;Ho C.-M.;Hu R.-H.;Ho M.-C.;Wu Y.-M.;Lee P.-H.;Liang P.-C. |
| 臺大學術典藏 |
2020-08-07T02:32:15Z |
Disease-free survival assessment by artificial?neural networks for hepatocellular carcinoma patients after radiofrequency ablation
|
Peng S.-F.; Chiu H.-W.; CHIH-HORNG WU; Liang P.-C.; Wu C.-F.;Wu Y.-J.;Liang P.-C.;Chih-Horng Wu;Peng S.-F.;Chiu H.-W.; Wu C.-F.; Wu Y.-J. |
| 臺大學術典藏 |
2020-08-07T02:32:13Z |
Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ? 2?cm with compensated liver cirrhosis
|
Lee P.-H.; Hu R.-H.; Lin C.-H.;Ho C.-M.;Chih-Horng Wu;Liang P.-C.;Wu Y.-M.;Hu R.-H.;Lee P.-H.;Ho M.-C.; Lin C.-H.; Ho C.-M.; CHIH-HORNG WU; Liang P.-C.; Wu Y.-M.; Ho M.-C. |
| 臺大學術典藏 |
2020-08-07T01:43:03Z |
A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma
|
Wong J.-M.; Chang Y.-T.; Liang P.-C.; Huang K.-W.; CHIEN-CHIH TUNG; Chang M.-C.; Chang F.-Y. |
| 臺大學術典藏 |
2020-08-06T07:51:51Z |
Quantification of hepatic steatosis: A comparison of the accuracy among multiple magnetic resonance techniques
|
TIFFANY TING-FANG SHIH; Lai H.-S.; Wu C.-H.; Ho M.-C.; Jeng Y.-M.; Hsu C.-Y.; Liang P.-C.; Hu R.-H. |
| 臺大學術典藏 |
2020-08-06T07:51:51Z |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Yu C.-W.; Chen B.-B.; Hsu C.-Y.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-08-06T07:51:50Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Liang P.-C.; Liu K.-L.; TIFFANY TING-FANG SHIH; Chen C.-H.; Hsu C.; Wu C.-H.; Chen B.-B.; Shih I.-L. |
| 臺大學術典藏 |
2020-08-06T07:51:50Z |
The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism
|
Liang P.-C.; Lai H.-S.; TIFFANY TING-FANG SHIH; Wu C.-H.; Huang K.-W. |
| 臺大學術典藏 |
2020-08-06T07:51:49Z |
Initial institutional experience of uncooled single-antenna microwave ablation for large hepatocellular carcinoma
|
Liang P.-C.; Lai H.-S.; TIFFANY TING-FANG SHIH; Wu C.-H.; Huang K.-W. |
| 臺大學術典藏 |
2020-08-06T07:51:48Z |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
TIFFANY TING-FANG SHIH; Liu T.W.; Chen L.-T.; Hsu C.; Liang P.-C.; Ch’ang H.-J. |
| 臺大學術典藏 |
2020-08-06T07:51:47Z |
Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US
|
Liang P.-C.; Hu R.-H.; Lai H.-S.; TIFFANY TING-FANG SHIH; Wu C.-H.; Ho M.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-08-06T07:51:46Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-08-06T07:51:44Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2020-08-06T07:51:43Z |
Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer
|
Lyadov V.K.; Liang P.-C.; Chen C.-M.; TIFFANY TING-FANG SHIH; Chang Y.-T.; Wu C.-H.;Chang M.-C.;Lyadov V.K.;Liang P.-C.;Chen C.-M.;Tiffany Ting-Fang Shih;Chang Y.-T.; Wu C.-H.; Chang M.-C. |
| 臺大學術典藏 |
2020-07-09T02:57:02Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:02Z |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Shih T.T.F.; Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y. |
| 臺大學術典藏 |
2020-07-09T02:57:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Chih-Wei Yu;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-06-19T02:27:17Z |
Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model
|
Wu W.-H.; Lee P.-H.; Hwang L.-H.; Chen D.-S.; Kai-Wen Huang;Wu H.-L.;Lin H.-L.;Liang P.-C.;Chen P.-J.;Chen S.-H.;Lee H.-I.;Su P.-Y.;Wu W.-H.;Lee P.-H.;Hwang L.-H.;Chen D.-S.; KAI-WEN HUANG; Wu H.-L.; Lin H.-L.; Liang P.-C.; Chen P.-J.; Chen S.-H.; Lee H.-I.; Su P.-Y. |
| 臺大學術典藏 |
2020-06-19T02:27:09Z |
The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism
|
Liang P.-C.;Lai H.-S.;Shih T.T.-F.;Wu C.-H.;Kai-Wen Huang; Liang P.-C.; Lai H.-S.; Shih T.T.-F.; Wu C.-H.; KAI-WEN HUANG |
| 臺大學術典藏 |
2020-06-19T02:27:08Z |
Micromachining NiTi tubes for use in medical devices by using a femtosecond laser
|
Hung C.-H.;Chang F.-Y.;Chang T.-L.;Chang Y.-T.;Kai-Wen Huang;Liang P.-C.; Hung C.-H.; Chang F.-Y.; Chang T.-L.; Chang Y.-T.; KAI-WEN HUANG; Liang P.-C. |
| 臺大學術典藏 |
2020-06-19T02:27:02Z |
A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma
|
Liang P.-C.;Kai-Wen Huang;Tung C.-C.;Chang M.-C.;Chang F.-Y.;Wong J.-M.;Chang Y.-T.; Liang P.-C.; KAI-WEN HUANG; Tung C.-C.; Chang M.-C.; Chang F.-Y.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2020-06-19T02:27:01Z |
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
|
Lee B.-C.;Liu K.-L.;Wu C.-H.;Kai-Wen Huang;Ho C.-M.;Hu R.-H.;Ho M.-C.;Wu Y.-M.;Lee P.-H.;Liang P.-C.; Lee B.-C.; Liu K.-L.; Wu C.-H.; KAI-WEN HUANG; Ho C.-M.; Hu R.-H.; Ho M.-C.; Wu Y.-M.; Lee P.-H.; Liang P.-C. |
| 臺大學術典藏 |
2020-06-19T02:27:01Z |
The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma
|
Kai-Wen Huang;Yang P.-C.;Pua U.;Kim M.-D.;Li S.-P.;Qiu Y.-D.;Song T.-Q.;Liang P.-C.; KAI-WEN HUANG; Yang P.-C.; Pua U.; Kim M.-D.; Li S.-P.; Qiu Y.-D.; Song T.-Q.; Liang P.-C. |
| 臺大學術典藏 |
2020-06-19T02:26:58Z |
Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer – A multi-institutional clinical study in Asia
|
Yang P.-C.;Kai-Wen Huang;Pua U.;Kim M.-D.;Li S.-P.;Li X.-Y.;Liang P.-C.; Yang P.-C.; KAI-WEN HUANG; Pua U.; Kim M.-D.; Li S.-P.; Li X.-Y.; Liang P.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Hsu C.-Y.; Chen B.-B.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Chih-Hung Hsu;Cheng A.-L.;Shih T.T.-F.; Liang P.-C.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Huang Y.-H.; Lee K.-T.; Wang C.-C.; Chau G.-Y.; Lee W.-C.; Ting C.-T.; Lee P.-H.; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Chia-Hsien Cheng;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-04-10T12:51:25Z |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
Liang P.-C.;Ch'Ang H.-J.;Chiun Hsu;Tseng S.S.;Shih T.T.F.;Wu Liu T.; Liang P.-C.; Ch'ang H.-J.; Chiun Hsu; Tseng S.S.; Shih T.T.F.; Wu Liu T. |
| 臺大學術典藏 |
2020-04-10T12:51:22Z |
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
|
Chang Y.-T.;Chang M.-C.;Wei S.-C.;Tien Y.-W.;Chiun Hsu;Liang P.-C.;Tsao P.-N.;Jan I.-S.;Wong J.-M.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; Chiun Hsu; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lin Z.-Z. |
